SeaStar Medical (ICU) Competitors

$4.49 -0.37 (-7.61%)

Closing price 05/8/2026 04:00 PM Eastern

Extended Trading

$4.62 +0.13 (+2.90%)

As of 05/8/2026 07:22 PM Eastern

ICU vs. DXR, DRIO, NSPR, LUNG, and ECOR

Should you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include Daxor (DXR), DarioHealth (DRIO), InspireMD (NSPR), Pulmonx (LUNG), and electroCore (ECOR). These companies are all part of the "medical equipment" industry.

How does SeaStar Medical compare to Daxor?

SeaStar Medical (NASDAQ:ICU) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

Daxor has higher revenue and earnings than SeaStar Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	14.60	-$12.15M	-$8.30	N/A
Daxor	$10.30M	4.87	N/A	N/A	N/A

SeaStar Medical presently has a consensus target price of $6.00, suggesting a potential upside of 33.63%. Given SeaStar Medical's higher probable upside, equities research analysts clearly believe SeaStar Medical is more favorable than Daxor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Daxor	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Daxor has a net margin of 0.00% compared to SeaStar Medical's net margin of -984.60%. Daxor's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-984.60%	-188.47%	-106.42%
Daxor	N/A	N/A	N/A

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 1.3% of Daxor shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Comparatively, 59.5% of Daxor shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, SeaStar Medical had 1 more articles in the media than Daxor. MarketBeat recorded 2 mentions for SeaStar Medical and 1 mentions for Daxor. SeaStar Medical's average media sentiment score of 0.98 beat Daxor's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SeaStar Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Daxor	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

SeaStar Medical has a beta of -1.04, indicating that its share price is 204% less volatile than the S&P 500. Comparatively, Daxor has a beta of 0.29, indicating that its share price is 71% less volatile than the S&P 500.

Summary

Daxor beats SeaStar Medical on 8 of the 13 factors compared between the two stocks.

How does SeaStar Medical compare to DarioHealth?

SeaStar Medical (NASDAQ:ICU) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

In the previous week, DarioHealth had 1 more articles in the media than SeaStar Medical. MarketBeat recorded 3 mentions for DarioHealth and 2 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.98 beat DarioHealth's score of 0.22 indicating that SeaStar Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SeaStar Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DarioHealth	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Comparatively, 3.5% of DarioHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

SeaStar Medical has higher earnings, but lower revenue than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	14.60	-$12.15M	-$8.30	N/A
DarioHealth	$22.36M	2.55	-$41.71M	-$10.43	N/A

SeaStar Medical has a beta of -1.04, indicating that its stock price is 204% less volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500.

DarioHealth has a net margin of -186.57% compared to SeaStar Medical's net margin of -984.60%. DarioHealth's return on equity of -59.48% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-984.60%	-188.47%	-106.42%
DarioHealth	-186.57%	-59.48%	-36.94%

SeaStar Medical currently has a consensus target price of $6.00, suggesting a potential upside of 33.63%. DarioHealth has a consensus target price of $35.00, suggesting a potential upside of 348.14%. Given DarioHealth's stronger consensus rating and higher probable upside, analysts clearly believe DarioHealth is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

DarioHealth beats SeaStar Medical on 11 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to InspireMD?

SeaStar Medical (NASDAQ:ICU) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

InspireMD has a net margin of -413.96% compared to SeaStar Medical's net margin of -984.60%. InspireMD's return on equity of -69.42% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-984.60%	-188.47%	-106.42%
InspireMD	-413.96%	-69.42%	-57.68%

In the previous week, InspireMD had 12 more articles in the media than SeaStar Medical. MarketBeat recorded 14 mentions for InspireMD and 2 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.98 beat InspireMD's score of 0.22 indicating that SeaStar Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SeaStar Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InspireMD	3 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

SeaStar Medical currently has a consensus target price of $6.00, suggesting a potential upside of 33.63%. InspireMD has a consensus target price of $4.50, suggesting a potential upside of 291.30%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

SeaStar Medical has a beta of -1.04, indicating that its stock price is 204% less volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500.

SeaStar Medical has higher earnings, but lower revenue than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	14.60	-$12.15M	-$8.30	N/A
InspireMD	$10.85M	4.97	-$19.92M	-$0.73	N/A

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Comparatively, 34.1% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

InspireMD beats SeaStar Medical on 12 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to Pulmonx?

Pulmonx (NASDAQ:LUNG) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.

91.0% of Pulmonx shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 6.8% of Pulmonx shares are owned by company insiders. Comparatively, 0.7% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, SeaStar Medical had 2 more articles in the media than Pulmonx. MarketBeat recorded 2 mentions for SeaStar Medical and 0 mentions for Pulmonx. SeaStar Medical's average media sentiment score of 0.98 beat Pulmonx's score of 0.03 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Pulmonx	Neutral
SeaStar Medical	Positive

Pulmonx has a net margin of -60.09% compared to SeaStar Medical's net margin of -984.60%. Pulmonx's return on equity of -92.94% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulmonx	-60.09%	-92.94%	-39.80%
SeaStar Medical	-984.60%	-188.47%	-106.42%

Pulmonx currently has a consensus target price of $5.38, suggesting a potential upside of 326.87%. SeaStar Medical has a consensus target price of $6.00, suggesting a potential upside of 33.63%. Given Pulmonx's stronger consensus rating and higher possible upside, equities research analysts plainly believe Pulmonx is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulmonx	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Pulmonx has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.04, indicating that its share price is 204% less volatile than the S&P 500.

SeaStar Medical has lower revenue, but higher earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulmonx	$90.50M	0.59	-$54M	-$1.30	N/A
SeaStar Medical	$1.23M	14.60	-$12.15M	-$8.30	N/A

Summary

Pulmonx beats SeaStar Medical on 11 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to electroCore?

electroCore (NASDAQ:ECOR) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

26.7% of electroCore shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 13.8% of electroCore shares are held by insiders. Comparatively, 0.7% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, electroCore had 6 more articles in the media than SeaStar Medical. MarketBeat recorded 8 mentions for electroCore and 2 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.98 beat electroCore's score of 0.43 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
SeaStar Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

electroCore has a net margin of -44.08% compared to SeaStar Medical's net margin of -984.60%. SeaStar Medical's return on equity of -188.47% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-44.08%	-1,956.38%	-83.30%
SeaStar Medical	-984.60%	-188.47%	-106.42%

electroCore presently has a consensus price target of $18.00, suggesting a potential upside of 180.81%. SeaStar Medical has a consensus price target of $6.00, suggesting a potential upside of 33.63%. Given electroCore's stronger consensus rating and higher probable upside, analysts plainly believe electroCore is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

electroCore has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.04, indicating that its stock price is 204% less volatile than the S&P 500.

SeaStar Medical has lower revenue, but higher earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$32.03M	1.66	-$13.97M	-$1.77	N/A
SeaStar Medical	$1.23M	14.60	-$12.15M	-$8.30	N/A

Summary

electroCore beats SeaStar Medical on 11 of the 16 factors compared between the two stocks.

Get SeaStar Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ICU vs. The Competition

Export

Metric	SeaStar Medical	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$19.42M	$8.21B	$6.25B	$12.12B
Dividend Yield	N/A	2.89%	2.78%	5.20%
P/E Ratio	-0.54	22.57	20.64	25.39
Price / Sales	14.60	17.56	534.02	75.96
Price / Cash	N/A	83.90	43.29	53.47
Price / Book	1.63	4.85	9.98	6.81
Net Income	-$12.15M	$183.43M	$3.54B	$333.04M
7 Day Performance	2.75%	0.60%	3.50%	3.17%
1 Month Performance	10.59%	6.08%	4.17%	7.14%
1 Year Performance	-64.08%	2.35%	41.86%	41.22%

SeaStar Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ICU SeaStar Medical	2.1656 of 5 stars	$4.49 -7.6%	$6.00 +33.6%	N/A	$19.42M	$1.23M	N/A	2	Upcoming Earnings
DXR Daxor	2.0453 of 5 stars	$11.89 +8.6%	N/A	N/A	$59.93M	N/A	N/A	37	Positive News Gap Up
DRIO DarioHealth	2.4926 of 5 stars	$7.40 -0.3%	$35.00 +373.0%	N/A	$54.02M	$22.36M	N/A	200	Upcoming Earnings Gap Down
NSPR InspireMD	4.15 of 5 stars	$1.14 -5.8%	$5.00 +338.6%	N/A	$53.46M	$8.98M	N/A	50	News Coverage Analyst Forecast Insider Trade
LUNG Pulmonx	2.0796 of 5 stars	$1.23 -4.3%	$5.38 +339.1%	N/A	$51.74M	$90.50M	N/A	250

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ICU) was last updated on 5/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SeaStar Medical (ICU) Competitors

ICU vs. DXR, DRIO, NSPR, LUNG, and ECOR

How does SeaStar Medical compare to Daxor?

Summary

How does SeaStar Medical compare to DarioHealth?

Summary

How does SeaStar Medical compare to InspireMD?

Summary

How does SeaStar Medical compare to Pulmonx?

Summary

How does SeaStar Medical compare to electroCore?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICU vs. The Competition

SeaStar Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SeaStar Medical (ICU) Competitors

ICU vs. DXR, DRIO, NSPR, LUNG, and ECOR

How does SeaStar Medical compare to Daxor?

Which has higher valuation & earnings, ICU or DXR?

Do analysts prefer ICU or DXR?

Is ICU or DXR more profitable?

Do insiders and institutionals have more ownership in ICU or DXR?

Does the media favor ICU or DXR?

Which has more volatility & risk, ICU or DXR?

Summary

How does SeaStar Medical compare to DarioHealth?

Does the media prefer ICU or DRIO?

Do institutionals and insiders hold more shares of ICU or DRIO?

Which has better earnings and valuation, ICU or DRIO?

Which has more volatility & risk, ICU or DRIO?

Is ICU or DRIO more profitable?

Do analysts recommend ICU or DRIO?

Summary

How does SeaStar Medical compare to InspireMD?

Is ICU or NSPR more profitable?

Does the media prefer ICU or NSPR?

Do analysts recommend ICU or NSPR?

Which has more volatility & risk, ICU or NSPR?

Which has better earnings and valuation, ICU or NSPR?

Do institutionals and insiders hold more shares of ICU or NSPR?

Summary

How does SeaStar Medical compare to Pulmonx?

Do insiders & institutionals hold more shares of LUNG or ICU?

Does the media prefer LUNG or ICU?

Is LUNG or ICU more profitable?

Do analysts recommend LUNG or ICU?

Which has more risk & volatility, LUNG or ICU?

Which has stronger earnings & valuation, LUNG or ICU?

Summary

How does SeaStar Medical compare to electroCore?

Do institutionals & insiders hold more shares of ECOR or ICU?

Does the media prefer ECOR or ICU?

Is ECOR or ICU more profitable?

Do analysts recommend ECOR or ICU?

Which has more volatility and risk, ECOR or ICU?

Which has higher valuation and earnings, ECOR or ICU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICU vs. The Competition

SeaStar Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools